Squarepoint
MRVI icon

Squarepoint’s Maravai LifeSciences MRVI Stock Holding History

Squarepoint’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-180,913
Closed -$400K – 4848
2025
Q1 		$400K Buy
+180,913
New +$715K ﹤0.01% 3496
2024
Q4 		– Sell
-71,959
Closed -$598K – 5339
2024
Q3 		$598K Sell
71,959
-283,631
-80% -$2.45M ﹤0.01% 2972
2024
Q2 		$2.55M Buy
355,590
+229,421
+182% +$1.98M ﹤0.01% 1864
2024
Q1 		$1.09M Sell
126,169
-183,851
-59% -$1.24M ﹤0.01% 2526
2023
Q4 		$2.03M Buy
+310,020
New +$2M ﹤0.01% 1983
2023
Q3 		– Sell
-265,700
Closed -$3.3M – 4075
2023
Q2 		$3.3M Buy
265,700
+98,399
+59% +$1.33M 0.01% 1334
2023
Q1 		$2.34M Buy
167,301
+119,467
+250% +$1.72M 0.01% 1328
2022
Q4 		$685K Buy
+47,834
New +$753K ﹤0.01% 2087
2022
Q2 		– Sell
-20,428
Closed -$720K – 3191
2022
Q1 		$720K Sell
20,428
-40,725
-67% -$1.37M ﹤0.01% 1791
2021
Q4 		$2.56M Buy
+61,153
New +$2.48M 0.01% 1112
2021
Q3 		– Sell
-186,062
Closed -$7.76M – 3233
2021
Q2 		$7.76M Buy
186,062
+34,062
+22% +$1.32M 0.03% 550
2021
Q1 		$5.42M Sell
152,000
-152,479
-50% -$5.05M 0.03% 592
2020
Q4 		$8.54M Buy
+304,479
New +$8.48M 0.06% 299

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Squarepoint's MRVI Position: Q2 2025 in Review

Squarepoint sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 180,913 shares — an estimated $400K sold.

Squarepoint first reported a position in MRVI in Q4 2020 and held it in 13 quarters. The position peaked at $8.54M in Q4 2020. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • Squarepoint reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Squarepoint sold 180,913 Maravai LifeSciences shares in Q2 2025, an estimated $400K.
  • Squarepoint first reported a position in Maravai LifeSciences in Q4 2020 and held it in 13 quarters.
  • Squarepoint's Maravai LifeSciences position peaked at $8.54M in Q4 2020.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.